Envoy Medical, Inc.
NASDAQ Capital MarketTotal Valuation
Envoy Medical, Inc. carries a market capitalization of 1.04M, placing it among publicly traded companies globally. Its enterprise value stands at -24.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.04M |
| Enterprise Value | -24.36M |
Share Statistics
Envoy Medical, Inc. currently has 76.88M shares outstanding.
| Shares Outstanding | 76.88M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 106.06 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Envoy Medical, Inc. maintains a current ratio of 2.27, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.42, indicating elevated leverage, while an interest coverage ratio of -20.83 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.27 |
| Quick Ratio | 2.07 |
| Debt / Equity | 8.42 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | -20.83 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -114.95 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.61 |
Stock Price Statistics
Envoy Medical, Inc.'s stock has declined approximately -17.08126% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.08126% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.05 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -22.81M, while operating income came in at -23.12M.
| Revenue | 234,000.00 |
| Gross Profit | -727,000.00 |
| Operating Income | -23.12M |
| Pretax Income | -23.11M |
| Net Income | -23.11M |
| EBITDA | -22.81M |
| EBIT | -23.12M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Envoy Medical, Inc. holds 25.25M in cash and equivalents against 889,000.00 in total debt, resulting in a net debt position of -25.25M. Total book value stands at -319.09M, with working capital of 15.47M providing operational flexibility.
| Cash & Cash Equivalents | 25.25M |
| Total Debt | 889,000.00 |
| Net Debt | -25.25M |
| Equity (Book Value) | -319.09M |
| Book Value Per Share | N/A |
| Working Capital | 15.47M |
Cash Flow
Envoy Medical, Inc. produced -20.54M in operating cash flow over the past twelve months.
| Operating Cash Flow | -20.54M |
| Capital Expenditures | -173,000.00 |
| Free Cash Flow | -20.71M |
| FCF Per Share | N/A |
Margins
Envoy Medical, Inc. operates with a gross margin of -310.68, reflecting its pricing power and cost economics. The operating margin of -9,881.20 and net profit margin of -9,875.64 provide insight into operational efficiency.
| Gross Margin | -310.68 |
| Operating Margin | -9,881.20 |
| Pretax Margin | -9,875.64 |
| Profit Margin | -9,875.64 |
| EBITDA Margin | -9,747.01 |
Dividends & Yields
The company's payout ratio of 15.69 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 15.69 |
| Shareholder Yield | N/A |
| FCF Yield | N/A |
Scores
Envoy Medical, Inc. posts an Altman Z-Score of -16.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -16.91 |